添加链接
link管理
链接快照平台
  • 输入网页链接,自动生成快照
  • 标签化管理网页链接
GetToolImpactFactorCommentsPageRequest(projectId=1, impactFactorId=7532, id=56a17532, selectType=1, sortType=1, contributeIds=null, level=null, parentIds=[]) [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)] [GetPortalCommentsPageByObjectIdResponse(id=2222448, encodeId=7ed92222448b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤分子生物学<br>经验分享:目前即时影响因子:7.45分,明年大概率能到12分。在影响因子下滑的时代,能连续多年维持10分以上,相当不容易,尤其是杂志并没有通过一些非常规手段:如,提前大半年发表文章,发表大量letter,发表过高比例的review,发表大量会议摘要,组件青年编委引用团队等,来操纵影响因子。被cancer research, 大CDD,advanced science 等拒了朋友,可以一试,机会很大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77772040306, createdName=1811e984f8m, createdTime=Mon Aug 26 13:08:22 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2222221, encodeId=a28c2222221d3, content=刚中了一篇这个,这杂志对青基作用大不?网上大家好像不是很看好的样子。有申请过的朋友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18838620417, createdName=ms4000000771872851, createdTime=Sat Aug 24 16:24:01 CST 2024, time=2024-08-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211174, encodeId=ff2022111e4dc, content=此杂志投稿会预印吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=16a16166362, createdName=莹儿飞, createdTime=Sat Jun 22 22:53:25 CST 2024, time=2024-06-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2194513, encodeId=896c219451396, content=有家人们一个月还没找到审稿人的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10fa8295255, createdName=ms5000000501352747, createdTime=Thu Mar 21 17:36:01 CST 2024, time=2024-03-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215516, encodeId=b7aa2215516e4, content=偏重的研究方向:肿瘤;分子机制;肿瘤分子生物学<br>经验分享:请问大家under review之后都是多久收到审稿意见的啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2485555070, createdName=ms7000001497079241, createdTime=Thu Jul 18 00:02:16 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143088, encodeId=165e214308883, content=偏重的研究方向:肿瘤;分子机制<br>经验分享:投稿6天reviewers assigned,当天under review。结果3天后又变成了reviewers assigned,请问这是没有找到审稿人吗?大家是否遇到过这种情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJN9OHDrdEGwpniaHlhT7OyAJsScbRwJ4Jauzia9ic9mYAzkGAW87ArL5zdkJzeY5pEgic8vFvdJyGibew/132, createdBy=65bd2215969, createdName=BALALA2, createdTime=Fri Jun 16 09:52:28 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196657, encodeId=0e1e219665ea7, content=under review五天后又变成reviewers assigned了。。这是同意审稿的人又放弃了吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:51:29 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2196654, encodeId=a37821966547c, content=审稿速度:2.0<br>经验分享:投稿四天后改格式重新投,然后第二天送审under review。。 过了六天怎么又重新reviewers assigned了。。 有谁知道这是什么情况吗。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e20f5652881, createdName=ms5000001046348584, createdTime=Tue Apr 02 15:49:23 CST 2024, time=2024-04-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2211603, encodeId=c7ad22116030f, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:四年的心血,前期投了一些杂志,有秒拒的,有审稿后给了意见拒的。文章也一直在根据意见修改提升。很感谢这个杂志,审稿很快,编辑和审稿人都很nice。4月21投,很快就审稿了,5月9号给大修,认真补了实验做了回复,6月18大修返回,6月24审稿人审完,6月25直接接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=ms3000000195618672, createdTime=Tue Jun 25 16:57:25 CST 2024, time=2024-06-25, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2127552, encodeId=8a99212e552be, content=请问,杂志现在需要提供全膜的wb嘛,谢谢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fee62100283, createdName=豆豆家的刺猬, createdTime=Fri Apr 21 22:48:51 CST 2023, time=2023-04-21, status=1, ipAttribution=天津)]